Backed by Decheng Capital, Loyal Valley Capital, OrbiMed, and Other Renowned Investors

SHANGHAI, April 29, 2026 /PRNewswire/ — Vivacta Biotechnology (Shanghai) Co., Ltd. (“Vivacta” or “Vivacta Bio”), an innovative biotechnology company focused on revolutionizing in vivo CAR-T therapies, announces the company recently completed Series A and Series A+ financing of over US$ 50 million. The two series of financing were led by Loyal Valley Capital and Decheng Capital respectively, and participated by renowned investors including OrbiMed, Hankang Capital, Eisai Innovation Inc., C&D Emerging Industry Equity Investment, as well as by existing shareholders such as Qiming Venture Partners, Beijing Shunxi, and Apricot Capital. Investors in Vivacta’s Series A and Series A+ financing comprised global industrial capital and specialist biotechnology investors, whose recognition highlights the potential of Vivacta’s innovative technologies and fuels accelerated clinical development and global operation of the company.

“We are deeply honored by the recognition and support from a group of leading investors“, commented Dr. Liu Yarong, Founder and CEO of Vivacta, “Vivacta is committed to advancing innovative in vivo CAR-T cell therapies. Our core product, GT801, has demonstrated promising safety and efficacy profiles in early clinical studies across hematological malignancies and autoimmune disease patients, potentially offering these patient populations a transformative treatment option to deliver innovative therapies to more patients in need.”

The proceeds from this financing round will be used to advance clinical trials for GT801, support GT801 regulatory submission and approval, expand research team and build out our platform, and accelerate Vivacta’s global expansion in the in vivo CAR-T field. Initial human data of GT801, Vivacta’s core project, was recently reported via an oral report at American Society of Hematology Annual Meeting & Exposition 2025 (ASH 2025) in December 2025. Upon closing of Series A+ financing, Mr. Xie Ronggang from Loyal Valley Capital and a partner from DC Global Ventures joined the board of directors of Vivacta.

About Vivacta

Vivacta is a biotechnology company dedicated to pioneering in vivo CAR-T cell therapy, committed to delivering transformative treatments for cancer patients and autoimmune disease patients. The Company’s flagship product, GT801, is a next-generation in vivo CAR-T therapy that has shown significant potential in early clinical studies for treating hematologic malignancies and autoimmune conditions.

About DC Global Ventures

DC Global Ventures is an investment firm that provides capital and strategic support to early-stage life science companies with revolutionary technologies and growth stage healthcare companies with strong market presence. We are a group of dedicated professionals with complementary expertise to build highly successful companies globally. Founded in 2012, DC Global Ventures continues to capitalize on a historic opportunity in the rapid growth of healthcare industry as well as breakthroughs in life science research. With over $2.5 billion in capital and the support from some of the most prestigious limited partners in the world, DC Global Ventures is poised to create value for our investors and entrepreneur partners.

About Loyal Valley Capital

Established in 2015, Loyal Valley Capital (LVC) is a thematic, research-driven private equity firm with strong entrepreneurial culture that invests in companies positioned to benefit from the secular industry transformations in China. LVC mainly focuses on three key sectors: New Consumer, Healthcare, and Advanced Manufacturing. We pride ourselves as a trusted influential shareholder by entrepreneurs, relentlessly focused on active value creation and accelerating growth via strategic initiatives through our extensive network of business leaders in China.

Loyal Valley Capital has built a robust portfolio of more than 110 outstanding leading companies nationwide. Our diversified portfolio covers representative companies across sectors, including Junshi Biosciences, Allist Pharmaceuticals, Henlius Biotech, Akeso Biopharma, Innovent Biologics, Caris Therapeutics, LBL Therapeutics, SurgiRobot, CoreMedic, UNISOC, Supcon Technology, EVE Energy, Biyi Space, Avary Holding, RIGOL Technologies, Qiangyi Semiconductor, Bilibili, Pop Mart, ByteDance, Xiaohongshu, and MAOGEPING. The firm maintains long-term industrial focus and cross-cycle investment vision, committing to delivering sustainable value creation for entrepreneurs, limited partners and the broader society by backing innovative and high-potential enterprises in key strategic industries.

About OrbiMed Advisors LLC

OrbiMed is a leading healthcare investment firm, with over $20 billion in assets under management. OrbiMed invests globally across the healthcare industry, from start-ups to large multinational corporations, through private equity funds, public equity funds, and royalty/credit funds. OrbiMed seeks to be a capital provider of choice, providing tailored financing solutions and extensive global team resources to help build world-class healthcare companies. OrbiMed’s team of over 130 professionals is based in New York City, London, San Francisco, Shanghai, Hong Kong, Mumbai, Herzliya, and other key global markets.

For more information, please visit www.orbimed.com.

Vivacta Contact

Yanwen Zhang
Email: yanwen.zhang@vivacta-bio.com
Telephone: +86-21-50828029

Driving Innovations from Chip to Grid Across Hyperscale and Local Data Centers

BARCELONA, Spain, April 29, 2026 /PRNewswire/ — The Open Compute Project Foundation (OCP), the nonprofit international organization bringing at-scale innovations and hyperscale best practices to all, today announced newly approved OCP contributions, new projects, and recently formed alliances to deliver on its Open Data Center Ecosystem for AI vision announced in October of 2025 covering IT as well as physical data center infrastructure and facilities.

The newly approved OCP contributions include (1) a roadmap for open data center facilities for AI, Next Generation ML Infrastructure Design Principles, (2) an overview of proposed direct current power distribution architectures Data Center Facility – Low Voltage DC Power Distribution, (3) guidelines for safe design, operation, and maintenance of energy storage systems  Requirements for Energy Storage Systems used in Data Centers, (4) new methods for gathering telemetry to enable data center real time IT and OT management Third Party Integration, Telemetry & APIs, (5) using Ethernet for AI scale-up networking  ESUN – Network Operator Requirements, (6) a major expansion to the Open Rack ecosystem for AI with the Open Rack Wide (ORW) specification (7) new reference architectures for building AI Clusters Open Cluster Designs for AI White Paper, Open POD Group for M xPUs, and Open Cluster of N xPUs, and (8) developing open chiplet ecosystems with the Foundation Chiplet System Architecture.

“These OCP approved contributions address critical problems for AI data centers, several of which were highlighted in an open letter call for collaboration initiated by Google, Meta, and Microsoft last October. The OCP Community, OCP Foundation Team, and the OCP Board of Directors have been hard at work to overcome the challenges from chip to grid of deploying AI Clusters at scale. With no end in sight to the very large AI data center buildout, the collaborations and innovation standardizations within the OCP Community are more important than ever,” said George Tchaparian, CEO at OCP.

To continue the collaborative work, recently launched projects and workstreams covering significant challenges still to be solved: (1) AI DC facilities: Open Data Center for AI and Data Center Facilities Power Distribution, (2) AI Clusters Connectivity: with Ethernet for Scale-Up Networking (ESUN), Scale-Up Ethernet Transport (SUE-T) and Optics Reliability, and (3) addressing the next wave of AI Inference: with the AI Computing Continuum.

Open Data Center for AI is focused on solving the most pressing challenges facing the deployment of at-scale AI data center facility infrastructure and operational technology (OT). This includes open data center reference designs, energy and grid solutions, telemetry and management solutions, and power estimation methodologies.

DCF Power Distribution aims to increase power density to enable next generation compute by enhancing energy efficiency and streamline power distribution, including the transition to Low Voltage Direct Current – LVDC (≤1500VDC) distribution architectures for the data center.

Scale-up Networking and Optics Reliability aims to advance Ethernet for scale-up domains in AI systems, re-examining how traffic is sent out across the network switches, including protocol headers, error handling, and lossless data transfer. Improving optics reliability with interoperability becomes critical because even a small failure rate across massive fabrics can cascade into significant interruptions, wasted accelerator hours, and degraded overall system utilization.

AI Computing Continuum aims to accelerate the adoption of scalable, interoperable, and sustainable AI systems beyond traditional hyperscale data centers by defining open, modular infrastructure standards that work across diverse hyperscale adjacent environments—including regional colocation, enterprise on premises, telco points of presence, and industrial sites.

We’ve also formed new alliances adding new dimensions to OCP’s ecosystem with (1) the Electric Power Research Institute (EPRI)  and (2) the IOWN Global Forum.

EPRI and OCP aim to accelerate digital innovation and further develop the potential of data centers to serve as flexible resources for the power system.

Current/OS and OCP focused on data center power technology standards and best practices. The alliance between the two organizations will fuse OCP’s expertise in open data center hardware with Current/OS’s open standards for safe, interoperable direct current microgrids. This alliance aims to accelerate the shift from traditional AC-based power to efficient hybrid AC/DC or fully DC-native data center infrastructure.

IOWN Global Forum and OCP are working to deliver a seamless computational infrastructure from centralized to edge deployments. IOWN Global Forum and OCP will work together to develop a roadmap for a multi-site, high-bandwidth, low-latency compute and network infrastructure.

“The need for extreme integration and co-design when designing AI clusters has become an imperative in the push to have a significant performance increment in generation over generation infrastructure. The move by the OCP Foundation to expand its Community footprint to cover from chip to grid is in perfect sync with the market and an important focus to deliver innovations needed for next generation AI data centers,” said Ashish Nadkarni, GVP/GM, Worldwide Enterprise Infrastructure at IDC.

About OCP

The Open Compute Project (OCP) brings at-scale innovations and hyperscaler best practices to all, spanning technology domains from the data center to the edge, and the technology stack from silicon, to systems, to site facilities and services. The international OCP Community is made up of organizations and people from hyperscale, neocloud and cloud data center operators, communications providers, colocation providers, diverse enterprises, and technology providers. With The OCP Tenets of Openness, Impact, Efficiency, Scale and Sustainability, the OCP Foundation engages with industry ecosystems, our growing membership, and educates thousands of engineers and industry leaders, every year. Across many projects and initiatives, the OCP Foundation and its Community are meeting the AI Data Center market evolution today and shaping the future. Learn more at: www.opencompute.org.

Media Contact
Dirk Van Slyke
Open Compute Project Foundation
dirkv@opencompute.org

Building on a long-standing MIT–IBM collaboration, the new lab will chart the convergence of AI, algorithms, and quantum computing

CAMBRIDGE, Mass., April 29, 2026 /PRNewswire/ — IBM (NYSE: IBM) and the Massachusetts Institute of Technology today announced the launch of the MIT-IBM Computing Research Lab, advancing their long-standing collaboration to shape the next era of computing. The new lab expands its scope to include quantum computing, alongside foundational artificial intelligence research, with the goal of unlocking new computational approaches that go beyond the limits of today’s classical systems.

Street‑level view of the MIT‑IBM Computing Research Lab in Cambridge, MA.

The MIT-IBM Computing Research Lab builds on a distinguished history of scientific excellence at the intersection of research and academia. Evolving from the MIT-IBM Watson AI Lab, which originated in 2017 on MIT’s campus, the new lab reflects a transformed technology landscape—one in which AI has entered mainstream deployment, and quantum computing is rapidly advancing toward practical impact. Together, MIT and IBM aim to help lead research in AI and quantum and to redefine mathematical foundations across both domains.

“We expect the MIT-IBM Computing Research Lab to emerge as one of the world’s premier academic and industrial hubs accelerating the future of computing,” said Jay Gambetta, director of IBM Research and IBM Fellow, and IBM chair of the MIT-IBM Computing Research Lab. “Together, the brightest minds at MIT and IBM will rethink how models, algorithms, and systems are designed for an era that will be defined by the sum of what’s possible when AI and quantum computing come together.”

“For a decade, the collaboration between MIT and IBM has produced leading-edge research and innovation, provided mentorship and supported the professional growth of researchers both at MIT and IBM,” said Anantha Chandrakasan, MIT’s provost, who as then-dean of the School of Engineering spearheaded the creation of the MIT-IBM Watson AI Lab and will continue as MIT chair of the lab. “The incredible technical achievements set the bar high for our work together over the next 10 years. I look forward to another decade of impact.”

Addressing the next frontiers in computation

The MIT-IBM Computing Research Lab will serve as a focal point for joint research between MIT and IBM in AI, algorithms, and quantum computing, as well as the integration of these technologies into hybrid computing systems. The lab is designed to accelerate progress toward powerful new computational approaches that take advantage of rapid advances in AI and quantum-centric supercomputing, including those that combine maturing quantum hardware with classical systems and advanced AI methods.

This research initiative will include improving capabilities and integrating AI with traditional computing, alongside pursuing advances in small, efficient, modular language model architectures, novel AI computing paradigms, and enterprise-focused AI systems designed for deployment in real-world environments, where reliability, transparency, and trust are essential.

In parallel, the lab will rethink the mathematical and algorithmic foundations that underpin the next era of computing by accelerating the development of novel quantum algorithms for complex problems, with impacts in areas such as materials science, chemistry, and biology.

Additionally, the lab will investigate mathematical and algorithmic foundations of machine learning, optimization, Hamiltonian simulations, and partial differential equations, which are used to approximate the behaviors of dynamical systems that currently stump classical systems’ scale and accuracy. Innovations from the lab could have wide implications for global industries, from more accurate weather and air turbulence prediction to better forecasts of financial market performance. Similarly, with improved optimization approaches, research from the lab could help lower risks in areas like finance, predict protein structures for more targeted medicine, and streamline global supply chains.

With its focus on AI, algorithms, and quantum, the MIT-IBM Computing Research Lab will complement and enhance the work of two of MIT’s strategic initiatives, the MIT Generative AI Impact Consortium and the MIT Quantum Initiative. MIT President Sally Kornbluth launched the strategic initiatives to broaden and deepen MIT’s impact in developing solutions to serious global challenges. The MIT-IBM Computing Research Lab will also leverage IBM’s longtime leadership and expertise in quantum computing. As part of its ambitious roadmap, IBM has laid out a clear path to delivering the world’s first fault-tolerant quantum computer by 2029, and is working across industries to drive value from quantum-centric supercomputing, tightly integrating quantum computers with high-performance computing and AI accelerators to solve the world’s toughest problems.

Deep integration with scientific domains

The MIT-IBM Computing Research Lab will also continue to serve as a foundation for training the next generation of computational scientists and innovators. It will do so by engaging faculty and students across MIT departments, enabling new computational approaches to accelerate discoveries in the physical and life sciences.

The lab will continue to be co-directed by Aude Oliva, senior research scientist at MIT’s Computer Science and Artificial Intelligence Laboratory, and David Cox, vice president, AI Foundations at IBM Research. MIT and IBM have appointed leads for each of the lab’s three focus areas – AI, algorithms, and quantum. Jacob Andreas, associate professor in the Department of Electrical Engineering and Computer Science (EECS), and Kenney Ng, principal research scientist at IBM Research and the MIT-IBM science program manager, will co-lead AI; Vinod Vaikuntanathan, the Ford Foundation Professor of Engineering in EECS, and Vasileios Kalantzis, IBM Research senior research scientist, will co-lead algorithms; and Aram Harrow, professor of physics, and Hanhee Paik, IBM director of Quantum Algorithm Centers, will co-lead quantum.

“The MIT-IBM Computing Research Lab reflects an important expansion of the collaboration between MIT and IBM and the increasing connections across AI, algorithms and quantum. This deepened focus also underscores a strong alignment with the MIT Schwarzman College of Computing’s mission to advance the forefront of computing and its integration across disciplines,” said Dan Huttenlocher, dean of the MIT Schwarzman College of Computing and MIT co-chair of the lab. “I’m excited about what this next chapter will enable in these three areas and their impact broadly.”

Building on nearly a decade of collaboration

The MIT-IBM Watson AI Lab helped pioneer a model for academic-industry research collaboration, aligning long-term scientific inquiry with real world impact. Since its inception, the lab has funded over 210 research projects involving over 150 MIT faculty members and over 200 IBM researchers. Collectively the projects have led to over 1,500 peer-reviewed articles. The lab also helped shape the career growth of a number of MIT students and junior researchers, funding more than 500 students and postdoctoral scholars.

“The true measure of this lab is not just innovation, but transformation of a field. Hundreds of students have contributed to thousands of publications in top conferences and journals, demonstrating their capabilities to address meaningful problems,” said Oliva. “The MIT-IBM Computing Research Lab builds on an extraordinary legacy of impact to advance a trusted collaboration that will redefine the future of AI and quantum computing in a way never seen before.”

“By coupling academic rigor with industrial scale, the lab aims to define the computational foundations that will power the next generation of AI, quantum, and scientific breakthroughs,” said Cox. “By bringing together advances in AI, algorithms, and quantum computing under one integrated research effort, we’re creating the conditions to rethink the mathematical and computational foundations of science and engineering.”

The MIT-IBM Computing Research Lab will capitalize on this foundation, expanding both the scientific scope and the ecosystem of collaborators across the Cambridge-Boston region and beyond.

About the MIT Schwarzman College of Computing

The MIT Schwarzman College of Computing addresses the opportunities and challenges for the computing age—from hardware and software to algorithms and artificial intelligence. Launched in 2020, the college advances the frontiers of computer science, AI, and other forefront areas of computing, infuses these fields across disciplines at MIT, and leads efforts to tackle the social, ethical, and policy dimensions of a rapidly evolving digital world. Visit computing.mit.edu for more information.

About IBM

IBM is a leading global hybrid cloud and AI, and business services provider, helping clients in more than 175 countries capitalize on insights from their data, streamline business processes, reduce costs and gain the competitive edge in their industries. Thousands of governments and corporate entities in critical infrastructure areas such as financial services, telecommunications and healthcare rely on IBM’s hybrid cloud platform and Red Hat OpenShift to affect their digital transformations quickly, efficiently and securely. IBM’s breakthrough innovations in AI, quantum computing, industry-specific cloud solutions and business services deliver open and flexible options to our clients. All of this is backed by IBM’s legendary commitment to trust, transparency, responsibility, inclusivity and service.

For more information, visit https://research.ibm.com.

Media Contacts

Brittany Forgione
IBM Research Communications
Brittany.Forgione@ibm.com

Ashley Peterson
IBM Research Communications
ashley.peterson@ibm.com 

IBM Corporation logo.

CHENGDU, China, April 29, 2026 /PRNewswire/ — Shanghai Stock Exchange listed company HitGen Inc. (“HitGen”, SSE: 688222.SH) released its 2025 Sustainability Report on April 29, 2026. This report is the second sustainability report of HitGen, aiming to present the Company’s philosophies and policies in environmental, social, and governance (“ESG”) areas, as well as its sustainable development practices and performance in the year of 2025, to systematically respond to stakeholder concerns.

Dr. Jin Li, Chairman of the Board and CEO of HitGen Inc., commented: “As an innovative biopharmaceutical enterprise committed to ‘contributing to human health’, HitGen has always believed that the core of a company lies in continuously creating value. In 2025, we remained dedicated to practical and determined actions, driving sustainable development to be integrated into strategy, embedded in management, and deeply rooted in operations. This strengthens the solid foundation for long-term success and enables us to continuously contribute, through tangible efforts from HitGen, to our customers, collaborators, investors, employees, as well as the environment and communities on which we depend.”

• Sustainable Corporate Governance

HitGen continuously optimizes its governance system, upholds the principle of integrity in business operations to set an industry benchmark, and establishes a comprehensive risk management system to promote long-term and stable development, creating sustainable value for all stakeholders.

• Responsible Value Chain

HitGen adheres to product safety and service quality, builds a sustainable supply chain, systematically manages all aspects of the value chain, and is committed to collaboratively creating long-term comprehensive value with stakeholders.

• Employees and Community

HitGen regards employees as the core driving force for sustainable development and communities as important partners for mutual growth. Adhering to a responsibility philosophy centred on people and dedicated to giving back to society, HitGen promotes employee growth and community co-development.

• Environment

HitGen adheres to the concept of green development, integrates environmental management into corporate operation and development strategies, and systematically advances environmental management, ecological protection, waste management, resource utilization, addressing climate change and other initiatives.

Dr. Jin Li said, “Every step counts, leading to great distances. On our journey to becoming a world-class innovative biopharmaceutical enterprise, we will continue to adhere to market demand as our guide and technological breakthroughs as our engine, continuously optimizing our innovative drug discovery services system, and contributing to building a more inclusive, healthy, green and accessible world.”

For more information on HitGen’s Sustainability Report, please visit:

https://www.hitgen.com/en/sustainability.html

About HitGen Inc.

HitGen Inc. (SSE: 688222.SH) is dedicated to building a world-class innovative biopharmaceutical enterprise. Driven by the mission to advance human health and quality of life, it provides innovative therapeutic solutions to address unmet medical needs. Centered on its internationally leading DEL (DNA-encoded Library) technology, the Company has expanded into Fragment-Based Drug Discovery and Structure-Based Drug Design and a suite of complementary platforms based on Oligonucleotide-based Therapeutics, Targeted Proximity Drugs, and Cyclic Peptidomimetics, and has developed HAILO, a proprietary “DEL+AI+Automation” molecular optimization platform, thereby establishing a distinctive novel molecule discovery engine that delivers both therapeutics molecules and tool molecules to the global pharmaceutical industry. Headquartered in Chengdu, China, HitGen maintains subsidiaries in Cambridge, UK, and Houston, USA, with its operational network spanning the globe. Through diversified and flexible business models including technical services, project out-licensing and product sales, the Company has forged extensive collaborations with a broad range of pharmaceutical and biotechnology companies, chemical firms, foundations, and research institutions. As of the end of 2025, it has empowered over 600 clients globally and contributed to thousands of their innovative drug development projects. HitGen also advances multiple internal programmes at various clinical and preclinical stages. For more information, please visit www.hitgen.com.